CHGA and neuroendocrine neoplasm: The clinical characteristics of our NEPC patient cohort are in line with previous reports, including the frequent presence of visceral metastases and paraneoplastic syndromes, as well as elevated neuroendocrine tumor markers (chromogranin A, NSE) [2, 16].